Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hospira touts non-DEHP offerings

This article was originally published in The Gray Sheet

Executive Summary

Lake Forest, Ill. firm announces plans to add 40 new infusion therapy medication delivery sets to its offerings of non-DEHP medical devices by early 2005. Hospira now markets roughly 80 products that do not use the polyvinyl chloride plasticizer, which, in 2003, was added to the California Environmental Protection Agency's Prop. 65 list of chemicals known to cause reproductive toxicity (1"The Gray Sheet" Oct. 27, 2003, In Brief). In 2002, FDA issued a 2public health notification recommending use of DEHP alternatives, followed by a 3draft guidance on PVC devices...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020948

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel